Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2010Cancer Immunology ImmunotherapyOpen Access

Response definition criteria for ELISPOT assays revisited

View Full Paper
Ask AI
Bookmark
Share

Authors

ZMZoe MoodieCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South AfricaLPLeah PriceCwm Taf University Health BoardCGCécile GouttefangeasGerman Cancer Research Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moodie et al. (2010) studied this question.

synapsesocial.com/papers/6a6f3c4a75498292b708a146https://doi.org/10.1007/s00262-010-0875-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program2010 · 29 citations
  2. 2More powerful procedures for multiple significance testing1990 · 2,847 citations
  3. 3Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment1993 · 943 citations